Pharma and HealthcareCase Study: Does Branding Impact Sales?How OSG helped a global pharmaceutical company evaluate and prioritize potential scientific statements intended to launch an unbranded campaign to educate physicians before the launch of Drug X.A global pharmaceutical company and its agency of record were planning to launch an unbranded campaign to shape the opioid-Induced nausea and vomiting (OINV) treatment market for the later launch of Drug X and thus wanted to test potential scientific statements that would boost this campaign. Using Dynamo, OSG’s AI-driven big data analytics platform, OSG conducted research in the United States to prioritize messages designed to launch a campaign that educates physicians about OINV and drives them to seek more information.Download Case Study - Unbranded Message Testing for a Global Pharmaceutical CompanyCheck out more of our case studies:Case Study: Personalized Marketing at ScaleHow OSG helped a global pharmaceutical company carve out its messaging strategy for targeted impact without sacrificing reach.Read moreCase Study: Optimizing Healthcare CostsHow OSG helped a global health insurer segment its customers, understand their lifetime value, and predict their engagement in the future, thereby establishing a product strategy for every customer segment.Read more
